Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03909334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03909334
- Sponsor
- Xiuning Le
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2026-12-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.